By continuing to use the site you agree to our Privacy & Cookies policy

Spend on new drugs expected to drop

The drugs industry expects the NHS to cut its real terms spend on new medicines over the next three years - but it is warning that the slow adoption of new drugs could create avoidable costs.

READ THE ARTICLE

Subscribe Today & Save 15%

  • Get the latest intelligence on NHS policy and agenda
  • Learn how healthcare leadership teams are getting it right, who’s getting it wrong and why
  • See how innovation is driving quality and efficiency at both local and national level
FIND OUT MORE

or

Sign up to get the latest health policy news direct to your inbox